Table 3

Cox-regression for all cause mortality

VariableHRCIP value
TR grade<0.001
 11.5730.930 to 2.6610.091
 21.8921.066 to 3.3590.029
 32.9341.569 to 5.4880.001
CKD (CKD-EPI GFR <60 mL/min)1.6021.283 to 2.001<0.001
LV systolic function0.014
 Mildly impaired (EF 45 –<55 %)1.0760.811 to 1.4260.613
 Moderately impaired (EF 35 –<45 %)1.4211.040 to 1.9420.027
 Severely impaired (EF <35 %)1.5631.128 to 2.1660.007
NT-proBNP (age adjusted cut-offs according to ESC21)1.4791.151 to 1.9000.002
TR progression (≥1 grade)1.4421.112 to 1.8140.006
sPAP (≥40 mm Hg)1.4351.249 to 1.649<0.001
RV function (TAPSE <18.5 mm)1.4311.143 to 1.7920.002
Aortic stenosis (at least moderate)1.3911.092 to 1.7730.008
Mitral regurgitation (at least moderate)1.2830.981 to 1.6780.068
Type 2 diabetes1.2581.015 to 1.5580.036
Afib1.2621.003 to 1.5880.047
  • Cox-regression analysis with backward elimination (using a p value>0.100 as removal criterion) for all-cause mortality, including cardiac and non-cardiac risk factors. Risk factors included were: TR grade, CKD, LV systolic function, NT-proBNP, sPAP, RV function, aortic stenosis, mitral regurgitation, type 2 diabetes, Afib, coronary artery disease, hypertension, implantable cardiac device (pacemaker or defibrillator) and sex.

  • Bold values denote statistical significance at the p≤0.05 level.

  • Afib, atrial fibrillation; CKD, chronic kidney disease; ESC, European Society of Cardiology; GFR, glomerular filtration rate; LV, left ventricular; NT-proBNP, N-terminal pro brain natriuretic peptide; RV, right ventricular; sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation.